These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 363377)

  • 1. Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.
    Chabner BA; Stoller RG; Hande K; Jacobs S; Young RC
    Drug Metab Rev; 1978; 8(1):107-17. PubMed ID: 363377
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of teniposide in patients with ovarian cancer.
    D'Incalci M; Rossi C; Sessa C; Urso R; Zucchetti M; Farina P; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):73-7. PubMed ID: 3967261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
    Tsuda N; Goto M; Konishi H; Yamashina H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):873-80. PubMed ID: 6326682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization and response to chemotherapy in a transplantable murine ovarian cancer.
    Ozols RF; Grotzinger KR; Fisher RI; Myers CE; Young RC
    Cancer Res; 1979 Aug; 39(8):3202-8. PubMed ID: 455304
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-dose methotrexate with blood monitoring in patients with osteosarcoma].
    Mordoh J; Medrano E; Chacón R
    Medicina (B Aires); 1978; 38(3):221-5. PubMed ID: 278905
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
    Parker LM; Griffiths CT; Yankee RA; Knapp RC; Canellos GP
    Cancer Treat Rep; 1979 Feb; 63(2):275-9. PubMed ID: 312692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of methotrexate as an anticancer drug.
    Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
    Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
    Blasberg RG; Patlak CS; Shapiro WR
    Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to intraperitoneal drug delivery.
    Howell SB; Kirmani S; Goel R
    Acta Med Austriaca; 1989; 16(3-4):61-4. PubMed ID: 2514552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device for constant Sc infusion of methotrexate: plasma results in mice.
    Pinedo HM; Zaharko DS; Dedrick RL
    Cancer Treat Rep; 1976 Jul; 60(7):889-93. PubMed ID: 1009520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possibility of selective chemotherapy of progressive recurring ovarian carcinoma with the aid of cytodiagnosis and incorporation of tagged idoxuridine].
    Dvorák O; Andrýsek O; Stránská E
    Geburtshilfe Frauenheilkd; 1969 Jul; 29(7):648-53. PubMed ID: 5799686
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of methotrexate uptake by human tumor cells from routine pathological samples.
    Curtis R; Wingard LB; Ladoulis CT
    J Med; 1978; 9(1):43-52. PubMed ID: 276561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
    Connor JP; Felder M
    Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of a Tenckhoff catheter in ovarian cancer].
    Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine rescue of high-dose methotrexate in humans.
    Howell SB; Ensminger WD; Krishan A; Frei E
    Cancer Res; 1978 Feb; 38(2):325-30. PubMed ID: 637906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung.
    Ihde DC; Johnston-Early A; Carney DN; Cohen MH; Bunn PA; Pelsor FR; Minna JD
    Cancer Treat Rep; 1982 May; 66(5):1223-5. PubMed ID: 6282453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.